Proteomics Intl Labs Ltd has released a press release.
Suspension from Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- New oesophageal cancer test presented at global conference
- OxiDx platform technology secures patent in Japan
- June 2023 Quarterly Activities Report and Appendix 4C
- Sonic Healthcare USA signs licence for PromarkerD in the US
- World Endometriosis Congress - New diagnostic test showcased
Later from Proteomics International Laboratories
- PromarkerD US reimbursement price & Aus regulatory decision
- Reinstatement to Quotation
- September 2023 Quarterly Activities Report and Appendix 4C
- Proteomics receives $1.85 million in R&D tax incentive
- US Medicare confirms reimbursement price for PromarkerD
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories